International Clinical Trial: A Study Looking at Continued Treatment with Setmelanotide for People with Rare Genetic Conditions or Other Rare Disorders That Affect Appetite and Body Weight

Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (EUCTR2026-000402-34-Outside-EU/EEA) titled 'A Study Looking at Continued Treatment with Setmelanotide for People with Rare Genetic Conditions or Other Rare Disorders That Affect Appetite and Body Weight' on Oct. 23.

Study Type: Interventional clinical trial of medicinal product

Study Design: Controlled: no Randomised: no Open: yes Single blind: no Double blind: no Parallel group: no Cross over: no Other: no If controlled, specify comparator, Other Medicinial Product: no Placebo: no Other: no

Primary Sponsor: Rhythm Pharmaceuticals, Inc.

Condition: Rare Genetic, Syndromic or Acquired Disease of the MC4R Pathway Therapeutic area: Diseas...